# Evaluation of Pandemic Influenza A (H1N1)Candidate Vaccines

> **NCT01111968** · PHASE1 · COMPLETED · sponsor: **Butantan Institute** · enrollment: 266 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** pandemic vaccine 1
- **BIOLOGICAL:** pandemic vaccine 2
- **BIOLOGICAL:** pandemic vaccine 5
- **BIOLOGICAL:** pandemic vaccine 6
- **BIOLOGICAL:** pandemic vaccine 9
- **BIOLOGICAL:** pandemic vaccine 10
- **BIOLOGICAL:** pandmeic vaccine 11
- **BIOLOGICAL:** pandmeic vaccine 12
- **BIOLOGICAL:** pandmic vaccine 13
- **BIOLOGICAL:** placebo group 14

## Key facts

- **NCT ID:** NCT01111968
- **Lead sponsor:** Butantan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-12
- **Final completion:** 2011-03
- **Target enrollment:** 266 (ACTUAL)
- **Last updated:** 2013-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01111968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01111968, "Evaluation of Pandemic Influenza A (H1N1)Candidate Vaccines". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01111968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*